FDA conditionally approves controversial Alzheimer’s drug despite uncertainty over effectiveness
Scientists can predict which women will have serious pregnancy complications
8 June 2021New ways of working will help patients and sustain our profession
8 June 2021FDA conditionally approves controversial Alzheimer’s drug despite uncertainty over effectiveness
The US Food and Drug Administration (FDA) has approved aducanumab (Aduhelm)—a drug which aims to delay clinical decline in patients with Alzheimer’s disease—despite concerns over a lack of…
